Abdulmaged M. Traish, PhD, MBA

Abdulmaged M. Traish, MBA, PhD, Research Director at The Institute for Sexual Medicine and Emeritus Professor of Urology, both at Boston University School of Medicine in Boston, MA, discusses what he calls a fundamental question—whether age-related testosterone deficiency (TD) should be treated. He cites data demonstrating that T therapy in older men with TD produces significant health benefits. Dr. Traish questions why the U.S. Food and Drug Administration (FDA) opposes testosterone (T) therapy in older men but not in men with classical hypogonadism, concluding his talk by asserting that age-related TD does, indeed, merit treatment and by respectfully disagreeing with the FDA stance.